IMSB-301

N/A

Report date: 2024/11/21 13:51:11
NME

Base Information

Drug NameIMSB-301
Drug Alias NameIMSB-301IMSB301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclic GMP-AMP synthase inhibitors
TargetsCyclic GMP-AMP synthase
Therapy Area/IndicationsType I InterferonopathiesInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesImmunesensor Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesImmunesensor Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsType I InterferonopathiesInflammationAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A